Certain Common Stock of Reneo Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 2-AUG-2023. These Common Stock will be under lockup for 91 days starting from 3-MAY-2023 to 2-AUG-2023.

Details:
Executive officers and directors, and certain affiliated stockholders have agreed, subject to specified exceptions, not to directly or indirectly sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open ?put equivalent position?, otherwise dispose of any shares of common stock, options or warrants to acquire shares of common stock, or securities exchangeable or exercisable for or convertible into shares of common stock currently or hereafter owned either of record or beneficially; or publicly announce an intention to do any of the foregoing for a period of 90 days after the date of this prospectus supplement without the prior written consent of Jefferies LLC, BofA Securities, Inc. and Piper Sandler & Co.